Fresh analysis indicates that individuals who discontinue new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who halt traditional lifestyle programs.
Research printed in a leading medical journal points out that while overweight individuals frequently drop substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"People using such drugs must be informed of the risk of quick rebound weight gain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery suggests a return to starting mass in about one and a half years.
Analyzing Approaches
The study, which reviewed dozens of trials involving thousands of patients, compared the results of these new drugs with older methods.
The team point out that individuals who shed pounds through lifestyle changes alone usually see a more gradual weight regain—approximately 100 grams monthly—after stopping.
The Reason for the Quick Regain
Doctors believe the way of the drugs is key to understanding the amplified weight return.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone levels several times higher than normal may cause the body to produce less of its endogenous GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement leads to appetite is no longer kept in check, making excessive eating much more probable."
A Chronic Disease?
The NHS advise the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts argue that, due to the high risk of relapse, the treatment should be considered long-term.
This view is echoed by pharmaceutical companies, who state that the results "underscore the chronic nature of excess weight," similar to managing conditions like hypertension.
User Accounts
Users who have stopped the jabs report a powerful resurgence of cravings.
"It felt as if a switch that goes on and I was suddenly extremely hungry," said a patient.
This difficulty is exacerbated if patients have not developed lasting lifestyle or habit changes during therapy.
Growing Adoption
Figures show that millions of adults in the UK have tried these injections in the past year, with demand remaining high.
- Use is more common among women than men.
- The middle-aged age group shows the highest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, researchers caution that while these medications are effective agents for weight loss, they are not a permanent cure and lasting health benefits hinges on ongoing behavioural changes.